表紙
市場調查報告書

活細胞影像觀察的全球市場未來展望 (2022年)

Live Cell Imaging Market Outlook 2022

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 923467
出版日期 內容資訊 英文 110 Pages
訂單完成後即時交付
價格
活細胞影像觀察的全球市場未來展望 (2022年) Live Cell Imaging Market Outlook 2022
出版日期: 2020年01月01日內容資訊: 英文 110 Pages
簡介

預估全球活細胞影像觀察市場規模將於2022年達70億美元規模。

本報告研究全球活細胞影像觀察市場,彙整技術概要和主要應用領域、市場基本結構與主要市場推動阻礙因素、市場規模實績與預測 (過去和未來4年),提供按產品、技術、應用、地區的詳細動向,以及資本交易和業務發展動向、主要企業簡介等情報。

第1章 分析師見解

第2章 研究方法

第3章 活細胞影像觀察:概要

第4章 全球活細胞影像觀察市場概要

第5章 市場動態

  • 推動因素
    • 慢性病發病率上升
    • 高內涵篩選技術需求激增
    • 官民雙方的資金援助額增加
    • 長期活細胞影像觀察平台的可用性
    • 透過活細胞影像觀察儀器加速新藥發現
  • 課題
    • 顯微鏡載物台上的活細胞維持
    • 體內微環境的模仿
    • 缺乏認知
  • 市場機會
    • 初級篩選之高內涵篩選系統的導入
    • 體內活細胞影像觀察技術的應用

第6章 活細胞影像觀察市場:按產品

  • 設備
  • 消耗品
  • 軟體

第7章 活細胞影像觀察市場:按應用

  • 細胞生物學
  • 生物發生學
  • 幹細胞生物學
  • 新藥發現
  • 其他應用

第8章 活細胞影像觀察市場:按技術

  • 螢光共振能量轉移 (FRET)
  • 高內涵分析 (HCS)
  • 螢光原位雜交 (FISH)
  • 其他技術

第9章 活細胞影像觀察市場:按地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第10章 市場趨勢與發展

  • 透過螢光探針強化活細胞影像觀察
  • Label-free/定量位相成像之LiveCyte的動態細胞儀:概要
  • 揭露細胞內交互作用的活細胞影像觀察
  • SPIM顯微鏡 (單平面照明顯微鏡) 的導入推動活細胞影像觀察

第11章 企業合併/其他業務合作

第12章 企業簡介

  • Carl Zeiss GmbH
  • Becton Dickenson & Co.
  • Olympus Corporation
  • ThermoFisher Scientific Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Nikon Instruments Inc.
  • GE Healthcare
  • Lonza
  • Danaher Corporation
目錄

Live Cell Imaging is defined as the study of living cells using high content screening or analysis systems and imaging systems such as microscopes, cell analyzers, etc. These technologies are used in number of investigations in order to provide critical insights into the fundamental nature of tissue and cellular function.

The new report introduced by RNCOS entitled "Live Cell Imaging Market Outlook 2022", includes a comprehensive analysis of the current and future outlooks of the Live Cell Imaging industry. The live cell imaging market is expected to reach US$ 7 Billion by 2022.

The report presents an in-depth analysis of several techniques used in imaging of live cells; as well as the segmentation of market by products, applications, technology and geography. Based on product types, the market has been segmented into equipments, consumables and softwares. Equipment market accounted for the largest share in 2017. According to technologies used in live cell imaging, the market has been divided into FRET, FISH, and other major techniques.

Similarly, geographical regions include North America, Europe, Asia Pacific and Rest of the World. North America is the largest market for live cell imaging due to high number of cell biology researches conducted in the region. As per RNCOS' analysis, live cell imaging is widely entering into a number of fields such as cell biology, developmental biology, drug discovery, stem cell biology, neurobiology and electrophysiology. It is emerging as a powerful tool for providing critical insights into cell function, including dynamic processes in living cells with nano-scale resolution in real time. Recent advances in microscopy techniques such as fluorescence light microscopy, including super resolution, photo activation, etc. and confocal microscopy are moving live cell imaging for a number of applications.

The last section of the report discusses about the prominent players in global live cell imaging market. A brief business overview and financial information about each of these players has been provided along with their product portfolios. The recent development and strength weakness analysis of every player has also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global live cell imaging market.

1. Analyst View

2. Research Methodology

3. Live Cell Imaging - An Introduction

4. Global Live Cell Imaging Market Overview

5. Market Dynamics

  • 5.1 Drivers
    • 5.1.1 Rising Incidences of Chronic Diseases
    • 5.1.2 Surging Demand for High-Content Screening Techniques
    • 5.1.3 Increasing Funding Support by Public and Private Sector
    • 5.1.4 Availability of Long-term Live Cell Imaging Platform
    • 5.1.5 Live Cell Imaging Instruments Accelerating Drug Discovery
  • 5.2 Challenges
    • 5.2.1 Maintaining Live Cells on Microscope Stage
    • 5.2.2 Mimicking the In Vivo Microenvironment
    • 5.2.3 Lack of Awareness
  • 5.3 Opportunities
    • 5.3.1 Adoption of High Content Screening Systems for Primary Screening
    • 5.3.2 Application of In Vivo Live Cell Imaging Techniques

6. Global Live Cell Imaging Market By Product

  • 6.1 Equipment
  • 6.2 Consumables
  • 6.3 Software

7. Global Live Cell Imaging Market by Application

  • 7.1 Cell Biology
  • 7.2 Developmental Biology
  • 7.3 Stem Cell Biology
  • 7.4 Drug Discovery
  • 7.5 Other Applications

8. Global Live Cell Imaging Market By Technology

  • 8.1 Fluorescent Resonance Energy Transfer (FRET)
  • 8.2 High Content Analysis (HCA)
  • 8.3 Fluorescence In Situ Hybridization (FISH)
  • 8.4 Other Technologies

9. Global Live Cell Imaging Market By Geography

  • 9.1 North America
  • 9.2 Europe
  • 9.3 Asia Pacific
  • 9.4 Rest of the World

10. Trends & Developments

  • 10.1 Fluorescent Probes Enriching Live Cell Imaging
  • 10.2 Introduction of LiveCyte Kinetic Cytometer for Label-free, Quantitative Phase Imaging
  • 10.3 Live Cell Imaging Revealing Intracellular Interactions
  • 10.4 Introduction of Single Plane Illumination Microscopy Advancing Live Cell Imaging

11. Mergers & Other Collaborations

12. Company Profiles

  • 12.1 Carl Zeiss GmbH
  • 12.2 Becton Dickenson & Co.
  • 12.3 Olympus Corporation
  • 12.4 ThermoFisher Scientific Inc.
  • 12.5 Merck KGaA
  • 12.6 PerkinElmer, Inc.
  • 12.7 Nikon Instruments Inc.
  • 12.8 GE Healthcare
  • 12.9 Lonza
  • 12.10 Danaher Corporation

List of Figures:

  • Figure 4-1: Global - Live Cell Imaging Market (Billion US$), 2016-2022
  • Figure 6-1: Global - Live Cell Imaging Market by Products (%), 2017
  • Figure 6-2: Global - Live Cell Imaging Equipment Market (Billion US$), 2016 & 2022
  • Figure 6-3: Global - Live Cell Imaging Consumables Market (Billion US$), 2016 & 2022
  • Figure 6-4: Global - Live Cell Imaging Consumables Market by Type(%), 2017
  • Figure 6-5: Global - Live Cell Imaging Software Market (Billion US$), 2016 & 2022
  • Figure 7-1: Global - Live Cell Imaging Market by Applications (%), 2017
  • Figure 7-2: Global - Live Cell Imaging Market for Cell Biology (Billion US$), 2016 & 2022
  • Figure 7-3: Global - Live Cell Imaging Market for Developmental Biology (Billion US$), 2016 & 2022
  • Figure 7-4: Global - Live Cell Imaging Market for Stem Cell Biology (Billion US$), 2016 & 2022
  • Figure 7-5: Global - Live Cell Imaging Market for Drug Discovery (Billion US$), 2016 & 2022
  • Figure 7-6: Global - Live Cell Imaging Market for Other Applications (Billion US$), 2016 & 2022
  • Figure 8-1: Global - Live Cell Imaging Market by Technology (%), 2017
  • Figure 8-2: Global - Live Cell Imaging Market for Fluorescent Resonance Energy Transfer (Billion US$), 2016 & 2022
  • Figure 8-3: Global - Live Cell Imaging Market for High Content Analysis (Billion US$), 2016 & 2022
  • Figure 8-4: Global - Live Cell Imaging Market for Fluorescence In Situ Hybridization (Billion US$), 2016 & 2022
  • Figure 8-5: Global - Live Cell Imaging Market for Other Technologies (Billion US$), 2016 & 2022
  • Figure 9-1: Global - Live Cell Imaging Market by Geography (%), 2017
  • Figure 9-2: North America - Live Cell Imaging Market (Billion US$), 2016 & 2022
  • Figure 9-3: Europe - Live Cell Imaging Market (Billion US$), 2016 & 2022
  • Figure 9-4: Asia Pacific - Live Cell Imaging Market (Billion US$), 2016 & 2022
  • Figure 9-5: Rest of the World - Live Cell Imaging Market (Billion US$), 2016 & 2022
  • Figure 12-1: Carl Zeiss GmBH - Revenue Breakup by Business Segments (%), FY 2017
  • Figure 12-2: Carl Zeiss GmBH - Revenue Breakup by Geography (%), FY 2017
  • Figure 12-3: Becton Dickenson & Co. - Revenue Breakup by Business Segments (%), 2017
  • Figure 12-4: Becton Dickenson & Co. - Revenue Breakup by Geography (%), 2017
  • Figure 12-5: Olympus Corporation - Revenue Breakup by Business Segments (%), 2017
  • Figure 12-6: Olympus Corporation - Revenue Breakup by Geography (%), 2017
  • Figure 12-7: Olympus Corporation - Revenue Breakup of Scientific Solutions Business by Geography (%), 2017
  • Figure 12-8: Thermo Fisher Scientific Inc. - Revenue Breakup by Business Segments (%), 2017
  • Figure 12-9: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 12-10: Merck KGaA - Breakup of Net Sales By Business Segments (%), 2017
  • Figure 12-11: Merck KGaA - Breakup of Net Sales By Geography (%), 2017
  • Figure 12-12: PerkinElmer Inc. - Revenue Breakup by Business Segments (%), 2017
  • Figure 12-13: PerkinElmer Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 12-14: Nikon Corporation - Breakup of Net Sales by Business Segments (%), 2017
  • Figure 12-15: Nikon Corporation - Breakup of Net Sales by Geography (%), 2017
  • Figure 12-16: GE Healthcare - Revenue Breakup by Business Segments (%), 2017
  • Figure 12-17: GE Healthcare - Breakup of Revenue by Geographies (%), 2017
  • Figure 12-18: Lonza - Breakup of Sales by Business Segments (%), 2017
  • Figure 12-19: Danaher Corporation - Breakup of Sales by Business Segments (%), 2017
  • Figure 12-20: Danaher Corporation - Breakup of Sales by Geography (%), 2017

List of Tables:

  • Table 5-1: Global - Cancer Mortality Cases (Million), 2015 & 2025
  • Table 5-2: Funds Announced for Live Cell Imaging Research (2013-2015)
  • Table 9-1: North America - Elderly Population (Million), 2015 & 2030
  • Table 9-2: North America - Cancer Incidences (Million), 2015 & 2025
  • Table 9-3: Europe - Elderly Population (Million), 2015 & 2030
  • Table 9-4: Europe - Cancer Incidences (Million), 2015 & 2025
  • Table 9-5: Asia Pacific - Elderly Population (Million), 2015 & 2030
  • Table 9-6: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
  • Table 9-7: Latin America - Elderly Population (Million), 2015 & 2030
  • Table 9-8: Latin America - Cancer Incidences (Million), 2015 & 2025
  • Table 9-9: Africa - Elderly Population (Million), 2015 & 2030
  • Table 9-10: Africa - Cancer Incidences (Million), 2015 & 2025
  • Table 12-1: Carl Zeiss GmBH - Key Financials (Million US$), FY 2015-FY 2017
  • Table 12-2: Becton Dickenson & Co. - Key Financials(Million US$), 2015-2017
  • Table 12-3: Olympus Corporation - Key Financials (Million US$), 2015-2017
  • Table 12-4: ThermoFisher Scientific Inc.- Key Financials (Million US$), 2015-2017
  • Table 12-5: Merck KGaA - Key Financials (Million US$), 2015 - 2017
  • Table 12-6: PerkinElmer Inc. - Key Financials (Million US$), 2015-2017
  • Table 12-7: Nikon Corporation. - Key Financials (Million US$), 2015-2017
  • Table 12-8:GE Healthcare - Key Financials (Million US$), 2015-2017
  • Table 12-9: Lonza - Key Financials (Million US$), 2015-2017
  • Table 12-10: Danaher Corporation - Key Financials (Million US$), 2015-2017